Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Non-Ablative Laser with an Advanced Biomimetic Peptide Formulation: Clinical Study to Evaluate the Safety and Efficacy of 1570 nm Non-Ablative Laser Combined with an Advanced Biomimetic
Sponsors
Dr Soujanya Dhulipala
Eligibility
Inclusion criteria
Inclusion criteria: 1. Have clinical diagnosis of pattern hair loss 2. Meet grading criteria (HN or Ludwig) 3. Have a clearly identifiable target scalp area 4. Be willing to comply with study procedures 5. Provide written informed consent
Exclusion criteria
Exclusion criteria: 1. Scarring alopecia 2. Alopecia areata or other non-pattern hair loss 3. Active scalp disease (infection, psoriasis, dermatitis) 4. Prior hair transplant in target area 5. Recent treatments, Minoxidil within 4 weeks; Finasteride/Dutasteride within 3 months; PRP/exosomes/microneedling within 3 months 6. Pregnancy / lactation 7. Uncontrolled systemic illness 8. Known hypersensitivity 9. Participation in another clinical study within 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment will be done using the Hair Pull Test, measured as the number of extracted hairs per pull from the same scalp region using a standardized technique.Timepoint: Week 0, Week 6, Week 12, Week 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment will be done using Global Photographic Assessment GPA on a 7-point scale ranging from greatly worsened to greatly improved.Timepoint: Week 0, Week 6, Week 12, Week 15;Assessment will be done using trichoscopic evaluation of: Terminal hair count Vellus hair count Mean hair shaft diameterTimepoint: Week 0, Week 6, Week 12, Week 15;Assessment will be done using a Subject Self Assessment Questionnaire evaluating perceived reduction in hair fall, improvement in hair density, improvement in scalp coverage, & increase in hair thickness.Timepoint: Week 6, Week 12, Week 15;Standardized photographs will be captured & compared across visits to document visible changes in scalp coverage & overall hair appearance.Timepoint: Week 0, Week 12, Week 15;Safety & tolerability will be assessed by recording local reactions & adverse events including erythema, edema, dryness, scaling, burning or stinging, itching, & any other adverse event.Timepoint: Week 0, Week 6, Week 12, Week 15 | — |
Countries
India
Contacts
Public ContactMs Kartiki Wani
The Esthetic Clinics (TEC )
Outcome results
None listed